Pharma Summit USA | Agenda
Get to know the speakers09:00 - 09:45
Keynote
Keynote: Accelerating Drug Discovery with AI
How machine learning is compressing early-stage drug discovery timelines from years to months.
Dr. Elena VasquezChief Medical Officer, Moderna
Dr. Anita RaoChief Medical Officer, Novartis
Marcus ChenVP Regulatory Affairs, Pfizer
10:00 - 10:45
Panel
Panel: Global Health Equity
Pharma leaders discuss access and affordability of new treatments across emerging markets.
Dr. Rachel KimHead of Digital Health, Johnson & Johnson
James WhitfieldVP, Regulatory Affairs, AstraZeneca
Dr. Sofia BergmanHead of Clinical Data Science, Roche
David OseiDirector, Patient Access, GSK
Dr. Priyanka MenonSVP, R&D, Merck
09:00 - 09:15
Keynote
Opening Remarks: Welcome to Pharma Summit USA
09:15 - 09:50
Keynote
Keynote: The Next Decade of Drug Development
- Where the pipeline is heading and what it demands operationally
- Balancing speed, cost and evidence quality
Dr. Elena VasquezChief Medical Officer, Moderna
09:55 - 10:40
Panel
Panel: Decentralised Trials — What Actually Stuck
- Which DCT elements survived the hype cycle
- Site, patient and regulator perspectives
Marcus ChenVP Regulatory Affairs, Pfizer
Andreas BeckHead of Clinical Data Science, Bayer
Dr. Peter LindqvistSVP, Clinical Operations, Bristol Myers Squibb
11:05 - 11:35
Keynote
Case Study: Cutting Study Start-Up Time in Half
- The bottlenecks that mattered most
- How the team rebuilt the process end to end
Grace AdeyemiHead of Patient Engagement, Amgen
11:40 - 12:10
Fireside Chat
Fireside Chat: Regulatory Strategy in a Multi-Region World
- Aligning submissions across FDA, EMA and PMDA
- Where divergence is growing
Dr. Yuki TanakaVP, Regulatory Affairs, Takeda
Dr. Omar FaroukGlobal Head of Medical Affairs, AstraZeneca
13:30 - 14:30
Workshop
Workshop: Real-World Evidence That Payers Accept
- Designing studies with access in mind
- Common methodological objections and how to pre-empt them
Amara NwosuHead of Real-World Evidence, Novo Nordisk
14:35 - 15:20
Panel
Panel: AI in Discovery — Signal vs Noise
- Where models are genuinely shortening timelines
- Validation and reproducibility in practice
Nadia HaddadChief Digital Officer, Biogen
Dr. Martin KovacExecutive Director, Translational Medicine, Gilead
Dr. Julien MarchandVP, Biostatistics, Regeneron
15:45 - 16:15
Keynote
Closing Keynote: Building the Resilient Manufacturing Network
Sarah DelacroixHead of Manufacturing Technology, Sanofi